SCHEMBL25550486

SCHEMBL25550486

COC(CC(C)C)c1ccc(OC(F)F)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ AOC3 Q16853 2/20 0.39
▸ PKM P14618 2/20 0.38
▸ MEN1 O00255 2/20 0.37
▸ KMT2A Q03164 2/20 0.37
▸ GAA P10253 1/20 0.35
▸ DRD1 P21728 1/20 0.35
▸ MAPK1 P28482 1/20 0.35
▸ L3MBTL1 Q9Y468 1/20 0.35
▸ ATM Q13315 2/20 0.34
▸ LMNA P02545 2/20 0.34
▸ ALDH1A1 P00352 1/20 0.34
▸ HSP90AA1 P07900 1/20 0.34
▸ HPGD P15428 1/20 0.34
▸ HTT P42858 1/20 0.34
▸ CCR6 P51684 1/20 0.34
▸ ALOX15 P16050 1/20 0.34
▸ GFER P55789 1/20 0.34
▸ ADAM17 P78536 1/20 0.34
▸ MAPT P10636 2/20 0.34
▸ KDM4E B2RXH2 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25545401 0.77 MEN1 (0.40) AOC3PKMMEN1KMT2AGAA
SCHEMBL8193605 0.74 TAAR1 (0.40) AOC3MEN1KMT2ALMNAALDH1A1
SCHEMBL2737266 0.73 MEN1 (0.44) PKMMEN1KMT2AGAADRD1
SCHEMBL15299245 0.71 ALDH1A1 (0.50) PKMMEN1KMT2AGAADRD1
SCHEMBL15368380 0.70 MAPK1 (0.36) PKMMEN1KMT2AGAADRD1
SCHEMBL24492651 0.70 MEN1 (0.42) PKMMEN1KMT2AGAADRD1
SCHEMBL3647104 0.70 ADRB2 (0.46) PKMMEN1KMT2AGAADRD1
SCHEMBL14996617 0.70 MEN1 (0.42) PKMMEN1KMT2AGAADRD1
SCHEMBL18290854 0.70 KMT2A (0.45) PKMMEN1KMT2AGAADRD1
SCHEMBL957779 0.70 ADRB2 (0.46) PKMMEN1KMT2AGAADRD1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230150997-A1 EIF4E INHIBITORS AND USES THEREOF PIC Therapeutics, Inc. 2023-05-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230150997-A1 EIF4E INHIBITORS AND USES THEREOF EIF4E, EIF4EBP1, EIF4A1 AOC3 4750/4885PKM 1204/4885MEN1 2104/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback